AnalyzeDirect

Tag Archives: Head and Neck Neoplasms/blood supply/drug therapy

Vascular priming enhances chemotherapeutic efficacy against head and neck cancer

Folaron M, Kalmuk J, Lockwood J, Frangou C, Vokes J, Turowski SG, Merzianu M, Rigual NR, Sullivan-Nasca M, Kuriakose MA, Hicks WL, Jr., Singh AK, Seshadri M. Vascular priming enhances chemotherapeutic efficacy against head and neck cancer. Oral Oncol. September 2013;49(9):893-902. Full Text – Open Access Publication Date September 2013 How Analyze was Used “All…

Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts

Cao S, Durrani FA, Toth K, Rustum YM, Seshadri M. Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts. Oral Oncol. June 2011;47(6):459-466. Full Text – Open Access Publication Date June 2011 How Analyze was Used “All post processing and analysis were performed using Analyze™ (AnalyzeDirect, Overland Park,…